A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients

被引：47
|
作者：
McMillan, DC [1 ]
OGorman, P [1 ]
Fearon, KCH [1 ]
McArdle, CS [1 ]
机构：
[1] UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
来源：
BRITISH JOURNAL OF CANCER | 1997年 / 76卷 / 06期
关键词：
gastrointestinal cancer; weight loss; megestrol acetate; ibuprofen; acute-phase response;
D O I：
10.1038/bjc.1997.463
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Advanced gastrointestinal cancer patients with weight loss and an acute-phase response (n = 15) were given megestrol acetate (480 mg day(-1)) and ibuprofen (1200 mg day(-1)) for 6 weeks. Overall, there was an increase in body weight (P = 0.01) and a reduction in C-reactive protein concentrations (P = 0.02), with no change in total body water (P = 0.24) over this period. This regimen may be an effective non-toxic treatment for cancer cachexia and is worthy of further study.
引用
收藏
页码：788 / 790
页数：3
相关论文
共 50 条
  • [41] Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer:: A randomized pilot study
    Persson, C
    Glimelius, B
    Rönnelid, J
    Nygren, P
    NUTRITION, 2005, 21 (02) : 170 - 178
  • [42] The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment-related Cachexia
    Couluris, Marisa
    Mayer, Jennifer L. R.
    Freyer, David R.
    Sandler, Eric
    Xu, Ping
    Krischer, Jeffrey P.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (11) : 791 - 797
  • [43] PHASE-III EVALUATION OF 4 DOSES OF MEGESTROL-ACETATE AS THERAPY FOR PATIENTS WITH CANCER ANOREXIA AND OR CACHEXIA
    LOPRINZI, CL
    MICHALAK, JC
    SCHAID, DJ
    MAILLIARD, JA
    ATHMANN, LM
    GOLDBERG, RM
    TSCHETTER, LK
    HATFIELD, AK
    MORTON, RF
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) : 762 - 767
  • [44] PHASE-III EVALUATION OF 4 DOSES OF MEGESTROL-ACETATE AS THERAPY FOR PATIENTS WITH CANCER ANOREXIA AND/OR CACHEXIA
    LOPRINZI, CL
    BERNATH, AM
    SCHAID, DJ
    MALLIARD, JA
    ATHMANN, LM
    MICHALAK, JC
    TSCHETTER, LK
    HATFIELD, AK
    MORTON, RF
    ONCOLOGY, 1994, 51 : 2 - 7
  • [45] MEGESTROL-ACETATE FOR TREATMENT OF CACHEXIA ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
    VONROENN, JH
    MURPHY, RL
    WEBER, KM
    WILLIAMS, LM
    WEITZMAN, SA
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) : 840 - 841
  • [46] Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
    Hong, Sungwoo
    Jeong, In Gab
    You, Dalsan
    Lee, Jae-Lyun
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (05) : 687 - 692
  • [47] Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia
    Vadell, C
    Segui, MA
    Gimenez-Arnau, JM
    Morales, S
    Cirera, L
    Bestit, I
    Batiste, E
    Blanco, R
    Jolis, L
    Boleda, M
    Anton, I
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 347 - 351
  • [48] Megestrol acetate:: a systematic review usefulness about the weight gain in neoplastic patients with cachexia
    Ruiz-Garcia, V
    Juan, O
    Hoyos, SP
    Peiró, R
    Ramón, N
    Rosero, MA
    García, YMA
    MEDICINA CLINICA, 2002, 119 (05): : 166 - 170
  • [49] Augmentation of Cancer Cachexia Components With Targeted Acupuncture in Patients With Gastrointestinal Cancers: A Randomized Controlled Pilot Study
    Grundmann, Oliver
    Yoon, Saunjoo L.
    Williams, Joseph J.
    Gordan, Lucio
    George, Thomas J., Jr.
    INTEGRATIVE CANCER THERAPIES, 2019, 18
  • [50] Megestrol acetate in the treatment of hormone refractory prostate cancer
    Osborn, JL
    Smith, DC
    Trump, DL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (03): : 308 - 310
12345